Evidence map›Paper›PMID 40913030›Full record

ArticleCommunications biology2025

Kinase interaction analysis predicts actions of the WNK-OSR1/SPAK pathway.

Clinton A Taylor, Ji-Ung Jung, Sachith Gallolu Kankanamalage, Justin Li, Magdalena Grzemska, Ankita B Jaykumar, Svetlana Earnest, Steve Stippec, Purbita Saha, Eustolia Sauceda and 1 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Clinton A TaylorDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.ORCID http://orcid.org/0000-0002-8283-3393
Ji-Ung JungDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.ORCID http://orcid.org/0000-0001-5362-5969
Sachith Gallolu KankanamalageDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Justin LiDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Magdalena GrzemskaDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Ankita B JaykumarDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Svetlana EarnestDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Steve StippecDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Purbita SahaDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.ORCID http://orcid.org/0000-0001-9532-1445
Eustolia SaucedaDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA.
Melanie H CobbDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, 75390, TX, USA. Melanie.Cobb@UTSouthwestern.edu.ORCID http://orcid.org/0000-0003-2540-5859

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Kathryn Ann O'Donnell · 2010 to 2026
$53.7M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2022 to 2026
$7.4M
WNK and TGF-beta in Endothelial MigrationR01HL147661 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2019 to 2022
$1.6M
WNK1/OSR1 axis in Hippocampal Insulin Signaling, Glucose Metabolism and Age-related Cognitive DysfunctionK99AG075161 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI JAYKUMAR, ANKITA BACHHAWAT · 2023 to 2024
$256k
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP210041NCI NIH HHS P30 CA142543NHLBI NIH HHS R01 HL147661NIA NIH HHS K99 AG075161NIDDK NIH HHS P30 DK127984U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) P30CA142543Welch Foundation I1243
6 · The paper itself

Abstract

The WNK-OSR1/SPAK protein kinase pathway regulates ion homeostasis and cell volume, but its other functions are not well understood. To discover undefined signaling functions, we utilized experimentally-derived binding specificity to predict interactions and relative affinities with the conserved C-terminal (CCT) domains of OSR1 and SPAK, which bind short linear motifs. The upstream kinases WNKs 1-4 and their relatives, the pseudokinases NRBP1/2, also contain CCT-like domains which have conserved folds and motif binding pockets. Motifs were scored using peptide arrays, conservation, cytosolic localization, and solvent accessibility. Out of nearly 3700 motifs in the human proteome, 90% of previously published motifs ranked in the top 2% of those predicted. Interactions with selected candidates, including TSC22D1 and CAVIN1, were validated, and their localization and/or modifications were coupled to changes in WNK1 signaling. We also identified additional motif variants and confirmed binding to the NRBP1 CCT-like domain. Our results stress the diverse functionality of CCT/CCT-like domains and implicates unexpected interactions driving WNK biology.

Indexed as

Protein Serine-Threonine KinasesSignal TransductionWNK Lysine-Deficient Protein Kinase 1Amino Acid MotifsHEK293 CellsHumansProtein BindingOXSR1 protein, humanProtein Serine-Threonine KinasesSTK39 protein, humanWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID40913030
PMCPMC12413468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.